Malaria & Arbovirus detection assays

The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).

NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.

These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.